Companies / Cullinan Therapeutics, Inc. / Transactions
Back to Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc.

All insider transactions

20 transactions

Date ↓MoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 5, 2026SellCommon StockMichaelson Jennifer
Executive
-8,000$15.68$125.4K170,844medium
Mar 5, 2026Other
Option exercise
Common StockMichaelson Jennifer
Executive
+4,000$4.30$17.2K178,844low
Feb 25, 2026SellCommon StockMichaelson Jennifer
Executive
-1,780$14.14$25.2K174,844low
Feb 24, 2026SellCommon StockSUMER JACQUELYN L
Executive
-3,601$14.47$52.1K128,089low
Feb 24, 2026SellCommon StockMichaelson Jennifer
Executive
-3,601$14.47$52.1K176,624low
Feb 24, 2026SellCommon StockAHMED NADIM
CEO
-13,515$14.47$195.6K390,803medium
Feb 24, 2026SellCommon StockJones Jeffrey Alan
Executive
-4,582$14.47$66.3K159,968low
Feb 23, 2026SellCommon StockMichaelson Jennifer
Executive
-1,752$13.99$24.5K180,225low
Feb 20, 2026SellCommon StockSUMER JACQUELYN L
Executive
-3,742$13.62$51.0K131,690low
Feb 20, 2026SellCommon StockMichaelson Jennifer
Executive
-8,000$14.30$114.4K181,977medium
Feb 20, 2026Other
Option exercise
Common StockMichaelson Jennifer
Executive
+8,000$4.30$34.4K189,977low
Feb 20, 2026SellCommon StockMichaelson Jennifer
Executive
-3,742$13.62$51.0K181,977low
Feb 20, 2026SellCommon StockFenton Mary Kay
Executive
-4,398$13.62$59.9K126,380low
Feb 20, 2026SellCommon StockJones Jeffrey Alan
Executive
-4,982$13.62$67.9K164,550low
Feb 20, 2026SellCommon StockAHMED NADIM
CEO
-16,381$13.62$223.1K404,318medium
Feb 18, 2026Other
Grant / award
Common StockMichaelson Jennifer
Executive
+57,500$0.00$0185,719low
Feb 18, 2026Other
Grant / award
Common StockFenton Mary Kay
Executive
+68,750$0.00$0130,778low
Feb 12, 2026SellCommon StockMichaelson Jennifer
Executive
-416$12.03$5.0K128,219low
Jan 22, 2026SellCommon StockMichaelson Jennifer
Executive
-4,000$12.30$49.2K128,635low
Dec 31, 2025Other
Grant / award
Common StockFenton Mary Kay
Executive
+27$6.49$17562,028low
← PrevPage 1 of 1Next →